Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Aid In Dying topic
No spam. Unsubscribe anytime.
New York Assembly approves medical aid in dying law after hours of debate
Summary
The Assembly passed a chapter amendment to the Medical Aid in Dying Act Feb. 3, 2026, 85–60, adding residency limits, in‑person attending‑physician exams except for 'extraordinary hardship,' mandatory mental‑health evaluations, recorded oral requests and DOH rulemaking; opponents warned of coercion and unattended deaths.
Get email alerts on the Medical Aid In Dying topic
No spam. Unsubscribe anytime.
ALBANY — The New York State Assembly on Feb. 3, 2026, approved a chapter amendment to the Medical Aid in Dying Act after several hours of questioning and debate, voting 85 in favor to 60 against.
Sponsor Assemblymember Emily Pollan, explaining Rules Report No. 77 and the chapter amendment, said the changes add“safeguards, restrictions, clarifying language, and some technical changes” to the existing law. Pollan told colleagues that the amendment requires attending physicians to perform an in‑person examination unless doing so would present an “extraordinary hardship,” while consulting physicians and mental‑health evaluators may rely on telehealth in some circumstances. She also said oral requests must be audio‑ or video‑recorded and retained, written requests must be witnessed by two people with no financial interest, and a mental‑health professional must provide a written attestation before a prescription is issued.
“Today is a historic day for New York State,” Pollan said during her explanation on the floor, framing the legislation as expanding “choice, easing suffering, and affirming that no one in New York state will ever again have to face the end of life without dignity, autonomy, support, and compassion.”
The sponsor and members repeatedly discussed residency and eligibility: the amendment limits access to New York residents and, according to the sponsor’s floor answers, requires two forms of proof dated within the prior six months. The bill retains a 6‑month terminal prognosis as the eligibility threshold and clarifies that the prognosis applies whether or not treatment is being provided.
Lawmakers pressed sponsors on several practical safeguards. Members asked who defines “extraordinary hardship” that could waive the in‑person exam; Pollan said the bill leaves many procedural specifics to the Department of Health (DOH), which the amendment charges with promulgating rules, including reporting requirements and guidance on safe disposal of unused medication. The sponsor said many details — such as disposal protocols and reporting elements — will be developed by DOH under the law.
Opponents on the floor voiced two central concerns. Several lawmakers warned of coercion and “self‑coercion” by patients under financial or social pressure, and noted there are no statutory post‑prescription checks to verify continued capacity before a medication is used. One member said the bill does not require that deaths be attended, raising the prospect of unattended deaths and unresolved chain‑of‑custody for lethal drugs. "I'll be continuing to vote no," one opponent said on the floor, and others urged stronger guardrails or a focus on expanding hospice and palliative care before adopting assisted‑dying legislation.
Supporters framed the law as adding protections and respecting patient autonomy. In floor explanations of vote, Assemblymember Kevin Cashman said the measure “is about compassion” and “preserving dignity” for terminally ill New Yorkers. Pollan and other backers cited experience from other states and said a small fraction of eligible patients use the option.
On procedural and enforcement questions, the sponsor said clinicians may opt out of participating and that professional misconduct standards would apply only to providers who elect to participate but then fail to follow statutory requirements. She said criminal liability could apply where a provider coerced a patient or otherwise violated criminal statutes.
Members also sought detail on cost and access: the sponsor said medication costs run in the neighborhood of $800 in other states and that private insurers vary; she said the law does not make the treatment eligible for Medicaid, though hospice care remains covered by Medicaid and Medicare. The sponsor said reporting requirements to DOH should allow oversight and that DOH would establish disposal and other protocols.
After members of both conferences explained their votes, the clerk announced the roll call: “Ayes, 85. Noes, 60.” The chair declared the bill passed. The clerk had earlier read a provision indicating the act’s effective timing during the last section reading on the floor.
The Assembly also advanced routine calendar business and took up ceremonial resolutions and guest introductions earlier in the session. The House adjourned and reconvened at a date set by the Speaker.
What changed: The amendment adds explicit procedural safeguards to the existing Medical Aid in Dying Act — residency proof, recording of oral requests, witness qualifications, a required mental‑health attestation, an in‑person attending‑physician examination unless an “extraordinary hardship” applies, and DOH rulemaking authority to set reporting and disposal rules.
What remains unresolved: Members asked for specifics DOH will have to set by regulation — including the precise definition of extraordinary hardship, how DOH will audit or verify telehealth waivers, detailed witness training or verification, and concrete disposal protocols for unused medication.
Next steps: With passage by the Assembly, the chapter amendment moves forward according to the legislative schedule and the DOH will be responsible for creating implementing rules and reporting requirements as specified in the legislation.
